A selective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats

Garzón, 1982, Dynorphin (1–13), a long-lasting inhibitor of opiate receptor binding in vitro, Life Sci., 31, 1789, 10.1016/0024-3205(82)90211-9

Huidobro-Toro, 1985, κ-Opiates and urination: pharmacological evidence for an endogenous role of the κ-opiate receptor in fluid and electrolyte balance, European J. Pharmacol., 107, 1, 10.1016/0014-2999(84)90084-0

Lord, 1977, Endogenous opioid peptides: multiple agonists and receptors, Nature, 267, 495, 10.1038/267495a0

Martin, 1976, The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, 517

Rothman, 1986, Morphine tolerance increases μ-noncompetitive δ binding sites, European J. Pharmacol., 124, 113, 10.1016/0014-2999(86)90130-5

Schmauss, 1987, Intrathecally administered dynorphin (1–17) modulates morphine-induced antinociception differently in morphine-naive and morphine-dependent rats, European J. Pharmacol., 135, 429, 10.1016/0014-2999(87)90695-9

Tulunay, 1981, Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia, J. Pharmacol. Exp. Ther., 219, 296

Von Voigtlander, 1983, U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol. Exp. Ther., 224, 7

Ward, 1983, Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice, J. Pharmacol. Exp. Ther., 224, 525